Elza Ferreira Firmo

Elza Ferreira Firmo

Auto-generated profile, based on publicly available information

Elza Ferreira Firmo

Universidade Federal de Pernambuco

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
EFElza Ferreira Firmo
Elza Ferreira Firmo
JJJorge Belém Oliveira Júnior
Jorge Belém Oliveira Júnior
ASAlexsandra Maria Lima Scavuzzi
Alexsandra Maria Lima Scavuzzi
LALuis Carlos Alves
Luis Carlos Alves
FBFábio Brayner
Fábio Brayner
ALAna Catarina de Souza Lopes
Ana Catarina de Souza Lopes
Multidrug resistant Klebsiella pneumoniae which carries blaNDM-1 and blaKPC-2 genes is a worldwide concern and combination antimicrobial therapy may be the only viable option. Therefore, the aim of this study was to investigate in vitro activity of combinations of polymyxin B (PMB) with meropenem (MEM), amikacin (AMK) and gentamicin (GEN) in subinhibitory concentrations against two clinical isolates of blaNDM-1, blaKPC-2 and AMEs and resistant to polymyxin B. In this study, synergy and bactericidal activity were evaluated by checkerboard and time-kill, against two clinical isolates of polymyxin B-resistant K. pneumoniae which are resistant to polymyxin B (PMB) and are carriers of the blaNDM-1, blaKPC-2, aac(3)-IIa, aac(6)-Ib aph(3)-VI and ant(2)-Ia genes. Five combinations using the antimicrobials polymyxin B, meropenem (MEM), amikacin (AMK) and gentamicin (GEN) were evaluated. The PMB / MEM and PMB / AMK combinations proved to be the best options against the K7R2 isolate, mainly because they demonstrated bactericidal activity when using subinhibitory concentrations of these antimicrobials. However, none of the studied combinations were bactericidal against the K11R2 isolate. In conclusion, the combinations used in this study showed synergy against NDM and KPC producing isolates, but, given the bactericidal activity, the combinations of PMB / MEM and PMB / AMK were the most active only against one isolate. It also can be concluded that the antimicrobials to which the bacteria were resistant could be part of these combinations.

18 July 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
CSCynthia Regina Pedrosa Soares
Cynthia Regina Pedrosa Soares
FSFelipe Rogerio Ferreira da Silva
Felipe Rogerio Ferreira da Silva
JJJorge Belém Oliveira Júnior
Jorge Belém Oliveira Júnior
PAPaulo Sergio Ramos Araujo
Paulo Sergio Ramos Araujo
EFElza Ferreira Firmo
Elza Ferreira Firmo
A resistência a carbapenemases em bacilos gram-negativas (BGN) tornou-se um problema mundial, elevando a taxa de morbidade e mortalidade. O método automatizado foi utilizado para identificação e suscetibilidade dos isolados. E o método molecular foi aplicado na detecção de bacilos gram-negativas (BGN) produtoras de carbapenemase. Um total de 205 BGN foram recuperados a partir de diferentes amostras clínicas, resistentes a carbapenemases. Os genes de resistência blaKPC (57,5%), blaVIM (30,2%), blaGES (17%), blaNDM (15%) e blaSPM (2,4%) foram recuperados a partir de isolados clínicos. O gene blaIMP não foi detectado em nenhum dos isolados. É preocupante que Pseudomonas aeruginosa e Acinetobacter baumannii representem a maioria dos isolados (61,6%) recuperados de infecções de diferentes sítios, com alta resistência a carbapenêmicos, carregando simultaneamente os genes blaKPC, blaGES e blaVIM, assim como encontrados também em Enterobactericeae. A carbapenemase mais prevalente foi blaKPC e blaVIM, seguida de blaNDM dentre os isolados multidroga resistentes. Esses resultados são um ameaça à saúde pública, configurando altas taxas de resistência, limitando as opções terapêuticas.